Presenting Partner

Life Insurance Corporation of India

Moneycontrol

Budget 2022

Associate Partners:

  • Kotak Mutual Fund
  • Pharmeasy
  • Indiabulls
  • SBI

Presenting Partner

Life Insurance Corporation of India

Moneycontrol

Budget 2022

Technology Partner

Dell Technologies

Associate Partners

Kotak Mutual Fund
Pharmeasy
Indiabulls
SBI
Register Now!“Unlock Credit” Pre-Budget discussion on “Solving the enterprise lending and borrowing puzzle in Budget 2022” 29th January at 3pm

AstraZeneca Pharma India Q1 net profit up 10% at Rs 6.39 cr

The company had posted a net profit of Rs 5.79 crore for the corresponding period previous fiscal, AstraZeneca Pharma India said in a BSE filing.

August 13, 2018 / 08:17 PM IST
We are in the last phase of the September quarter earnings season, and the results announced by the BSE 500 companies so far have shown signs of a sharp recovery, as compared to the June quarter, when the economic activity in the country was compromised due to lockdown in various regions. From the BSE 500 list, 216 companies have announced their September quarter results so far. We excluded banking and financial companies.  Along with the index stocks we also analyse each sector quarterly earnings. (Data Source: ACE Equity)

We are in the last phase of the September quarter earnings season, and the results announced by the BSE 500 companies so far have shown signs of a sharp recovery, as compared to the June quarter, when the economic activity in the country was compromised due to lockdown in various regions. From the BSE 500 list, 216 companies have announced their September quarter results so far. We excluded banking and financial companies.  Along with the index stocks we also analyse each sector quarterly earnings. (Data Source: ACE Equity)

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm AstraZeneca Pharma India today reported a 10.36 per cent rise in its net profit to Rs 6.39 crore for the quarter ended June 30.

The company had posted a net profit of Rs 5.79 crore for the corresponding period previous fiscal, AstraZeneca Pharma India said in a BSE filing.

The company's revenue from operations stood at Rs 161.43 crore for the quarter under consideration. It was Rs 128.46 crore in the same period a year ago.

Shares of AstraZeneca Pharma India today closed at Rs 1,722.70 per scrip on BSE, down 2.08 per cent from its previous close.
PTI
first published: Aug 13, 2018 08:15 pm
Sections
ISO 27001 - BSI Assurance Mark